Content Type: Article

  • COVID-19 – The Impact on German Corporate Law

    COVID-19 – The Impact on German Corporate Law

    ARTICLE / CLIENT ALERT

    COVID-19 – The Impact on German Corporate Law

    March 27, 2020

    Read time: 6 min

    Key takeaways
    Overview

    The protective measures to prevent the spread of COVID-19, in particular the restrictions of the individuals’ right to convene, limit the ability to act for companies of different legal forms under German law.

    In depth

    Temporarily, companies are unable to hold shareholders’ meetings in the physical presence of their shareholders. However, meetings with physical presence are required by law for public limited company (Aktiengesellschaft – AG), partnership limited by shares (Kommanditgesellschaft auf Aktien – KGaA) and Societas Europaea (SE). This applies particularly to the annual general meeting, where distribution of an entity’s net profit is resolved.

    For a limited liability company (GmbH), the law provides for the adoption of resolutions in physical meetings as well. Outside of a meeting, shareholder resolutions may only be adopted if all shareholders agree thereto.

    The implementation of mergers and spin-offs pursuant to the German Transformation Act (Umwandlungsgesetz – UmwG) – in addition to the above mentioned issue regarding the holding of physical shareholders’ meetings – may be impeded by the fact that these measures must be registered with the commercial register within eight months from the effective date of the relevant closing balance sheet.

    BILL ON CORPORATE LAW MEASURES TO FIGHT THE IMPACT OF THE COVID-19 PANDEMIC

    To enable the affected companies of different legal forms to remain flexible to acting despite the restrictions of the individuals’ right to convene, the German parliament (Bundestag) adopted the bill on the mitigation of the COVID-19 pandemic’s consequences inter alia in corporate law on 25 March 2020. The Federal Council agreed to this bill during its session on March 27 2020. This means it can come into force before the end of March following execution by the Federal President, which is expected shortly. The law will apply retroactively as of March 1 2020. It provides the following facilitation for the adoption of resolutions in general and shareholders’ meetings, limited to the calendar year 2020:

    PUBLIC LIMITED COMPANY, PARTNERSHIP LIMITED BY SHARES, SOCIETAS EUROPAEA (SE)

    • A general meeting can take place as a virtual general meeting without the physical presence of the entity’s shareholders if:
      •  the entire meeting is transmitted by video and audio transmission,
      • the shareholders’ exercise of voting rights via electronic communication (postal vote or electronic participation) or by granting power of attorney is possible,
      • the shareholders are given the opportunity to ask questions by means of electronic communication, and
      • the shareholders without appearing physically at the site of the meeting, are given the opportunity to file an objection to any of the general meeting’s resolutions.
    • The board of directors can permit the participation of the shareholders or their representatives in the general meeting by use of electronic communication devices as well as the participation of the supervisory board members by means of video and audio transmission even without an authorization thereto in the entity’s articles of association.
    • The shareholders’ right to challenge resolutions of the general meeting, in particular on the grounds of deficiencies of the electronic communication options or the implementation of the virtual general meeting per se, is widely restricted.
    • The annual general meeting, which shall receive the approved annual accounts and resolve on the distribution of the net profit, can be convened at any time within the fiscal year instead of within the first eight months, as long as the new date still falls within the calendar year 2020. However, this provision does not apply to the Societas Europaea (SE).
    • Shortened convocation period – Instead of the minimum convocation period of 30 days, the board of directors is entitled to convene the general meeting no later than on the 21st day before the day of the meeting. For listed companies, the proof of share ownership must refer to the beginning of the twelfth day before the meeting.
    • Requests for amendments of the agenda must be received by the company at least 14 days (instead of 24 or 30 days in case of listed companies) before the meeting.
    • Even without authorization in the entity’s articles of association, the board of directors can resolve on an advance payment on the net profit (“interim dividend”) subject to the remaining statutory requirements.

    LIMITED LIABILITY COMPANY

    Ordinary shareholder resolutions can be adopted in text form or by written vote even without the consent of all shareholders to this form of adopting resolutions.

    TRANSFORMATION LAW

    For the duration of the calendar year 2020, the application to the commercial register of a merger or spin-off can be made up to twelve months (instead of eight months) after the balance sheet date.

    TRANSITIONAL ARRANGEMENTS

    The outlined modifications to the law of the public limited company, partnership limited by shares and Societas Europaea (SE) apply to general meetings taking place and advance payments on the net profit being distributed in the course of the calendar year 2020 only. Equally, the measures regarding the adoption of resolutions in a limited liability company and the application of measures under transformation law apply to shareholder resolutions adopted and applications to the commercial register made in the course of the calendar year 2020 only.

    The Federal Ministry of Justice and Consumer Protection (Bundesministerium der Justiz und für Verbraucherschutz – BMJV) is entitled to extend the application of the modifications by statutory instrument (Rechtsverordnung) without further consent of the States’ Council (Bundesrat) up until December 2021 31, if this appears necessary due to the continued impact of the COVID-19 pandemic in the Federal Republic of Germany.

    The bill on the mitigation of the COVID-19 pandemic’s consequences in private, insolvency and criminal proceedings law (BT-Drucksache 19/18110).

    Authors
    More insights

  • Where There’s a Will There’s a Way – Executing Wills During COVID-19

    Where There’s a Will There’s a Way – Executing Wills During COVID-19

    ARTICLE / CLIENT ALERT

    Where There’s a Will There’s a Way – Executing Wills During COVID-19

    March 27, 2020

    Read time: 5 min

    Key takeaways
    Overview

    In these uncertain times, many clients are considering putting their affairs in order—just in case the worst should happen. This is an entirely natural reaction to the advancing Coronavirus (COVID-19) epidemic. But where a client is in self-isolation, social-distancing or now affected by strict lockdown measures, the practical side of signing a new will presents significant challenges. This article takes a look at those challenges and suggests ways in which these can be overcome to enable a client to put in place a new will.

    In depth

    Signing a Will – The Formal Requirements

    The formal requirements for the signing of an English will date from the Wills Act, 1837. They are:

    • The will must be in writing, and the testator or testatrix must sign it, or another person must sign it in their presence and at their direction.
    • It must appear that the testator or testatrix intended by their signature to give effect to the will.
    • The signature must be either made or acknowledged in the presence of at least two witnesses present at the same time.
    • Each witness must sign the will, or acknowledge their signature, in the presence of the testator or testatrix (but not necessarily in the presence of any other witness).

    The Challenge During COVID-19

    These formal requirements create the need for at least three individuals (the person signing the will and two witnesses) to be present together at the same time, all able to see one another during the signing of the will, and all adding their signatures to the same hard copy document. It is important to note that the witnesses cannot be persons who benefit under the will or who are appointed as executors. For many people, this means that members of their immediate household are disqualified from being witnesses.

    Although electronic signatures have become acceptable for many legal documents in recent years, this has not been the case for wills, with wills one of the category of documents omitted from recent Law Society guidance on electronic signatures. In 2017, the Law Commission undertook a consultation on modernising the law relating to wills, including whether to allow electronic wills and to enable the court to dispense with formalities where the deceased’s wishes are clear. The progress of reform was paused when the government asked the Law Commission to focus on reforming the law relating to weddings as a priority. The gradual movement toward reform has now been overtaken by events, and we find ourselves in an unprecedented situation where the formal requirements of making a will may, paradoxically, prevent many clients from being able to put in place a valid will.

    Can I Still Make a Will?

    It will be possible for many clients to make a new will in the present circumstances. The UK government has recognised the importance of people being able to make wills by designating solicitors who are acting in the execution of wills as “key workers”. In many cases, it will be possible to provide instructions for the new will over the telephone or on videoconferencing facilities. These are important to assess other key requirements, such as the mental capacity of the client to make a will and to ensure that there is no undue influence being exerted on the client.

    McDermott has prepared detailed will signing instructions that take account of Public Health England guidelines on maintaining social distancing and on hand hygiene. If witnesses can be found who are willing to act, this can provide a solution.

    There may also be a technological solution available in the form of electronic signatures for the testator and the two witnesses (preferably solicitors), being present via a video meeting. Solicitors Regulation Authority has suggested considering electronic signatures for wills in circumstances where in-person witnessing is not practicable. While this does not meet the strict formal requirements for the valid signing of a will, it may nevertheless be an option when there is no other alternative. There is no official confirmation from the UK authorities that this will be accepted; however, we understand that it is being considered by government, along with other options for ‘deformalising’ the making of wills. The options under consideration are understood to include giving judges more flexibility when deciding what constitutes a will, a process where wills could be witnessed electronically, and allowing testators to write wills by hand without witnesses. This last option is similar to some features of the existing concept of a ‘privileged will’, currently only available to serving members of the armed forces.

    While the outcome of discussions is awaited, the guidance available so far is that using technological solutions provides an answer where there is no practical alternative. Full notes should be kept by the lawyers of the circumstances as well as reasons for using electronic signatures and video witnessing in case the will is submitted to probate and to maximise the chances it will be treated as valid.

    Once the COVID-19 measures have been lifted, any wills signed using such technologies can be updated by signing a new version of the will in compliance with the formalities required by the Wills Act.

    Authors
    More insights

  • White Collar Enforcement During the Coronavirus Crisis

    White Collar Enforcement During the Coronavirus Crisis

    ARTICLE / CLIENT ALERT

    White Collar Enforcement During the Coronavirus Crisis

    March 27, 2020

    Read time: 15 min

    Key takeaways
    Overview

    The COVID-19 pandemic has caused the dislocation of the world’s financial markets. Equity markets in the United States have been incredibly volatile and at one point, had lost more than 30% of their value. Local and national policies in response to the pandemic are changing constantly, with dramatic impacts on businesses of all sizes. At the moment, no one knows what the total impact will be or when the situation will start to turn around for the better.

    Historically, the SEC and DOJ have become very active in the aftermath of severe market dislocations, both to enforce existing law and to make examples out of those who — at least in the government’s eyes — took unfair advantage of the chaos. Following the 2008 financial crisis, for example, the SEC instituted proceedings against more than 200 entities and individuals, including 93 CEOs, CFOs and other senior corporate officials, collecting nearly $4 billion in penalties, disgorgement and other monetary relief.[1]

    The market volatility we are experiencing now during the coronavirus crisis will very likely cause the government to initiate numerous investigations. The Attorney General has directed all U.S. Attorneys “to prioritize the detection, investigation, and prosecution of all criminal conduct related to the current pandemic,” considering it “essential that the Department of Justice remain vigilant.”[2] In this regard, the government will likely employ a variety of statutes and theories to prosecute abuses in the securities markets and everywhere else that scams and schemes emerge.

    Insider Trading

    After the 2008 financial crisis, the government closely examined trading activity and aggressively pursued conduct it suspected to be insider trading. The DOJ instituted the most wide-ranging series of insider trading prosecutions in history after the 2008 financial crisis to hold many companies — and importantly, individuals — accountable. In these matters, the government sought ill-gotten gains, penalties and to impose significant prison sentences.[3]

    In response to the current crisis, the co-directors of the SEC Division of Enforcement recently warned that “a greater number of people may have access to material nonpublic information than in less challenging times,” increasing the potential for insider trading.[4]

    Four aspects of insider trading law will be key to the coming investigations.

    First, the government is likely to rely upon Rule 10b5-1. Generally, for a transaction to constitute insider trading under Rule 10b5-1, the person must make the trade “on the basis of” material nonpublic information. Rule 10b5-1 defines this phrase to include merely being “aware” of material nonpublic information at the time of the trade, even if the information was not the only reason for the trade. Although there is a circuit split as to whether the Rule applies to insider trading prosecutions,[5] the language of this Rule allows the SEC, at the very least, to bring a civil action against any person or firm who traded while in possession of material nonpublic information, regardless of any separate motivation they may have had for their trades.[6]

    Second, the government will thoroughly pursue downstream tipping. Under Section 10(b) and Rule 10b-5, the source and the ultimate recipient of material nonpublic information can be liable as “tipper” and “tippee” assuming the appropriate elements are met. Liability attaches where the tipper breached a duty of trust or confidentiality in divulging the information and received a “personal benefit” for doing so.[7] (SRZ Alert, Second Circuit, in Split Decision, Overrules Limitation on Insider Trading Liability Established in U.S. v. Newman) Given how quickly new, material information is developing in the current volatile market, the government can be expected to scrutinize closely whether information that ultimately results in well-timed trades emanates from persons who owe a duty of trust or confidentiality.

    Third, the government may return to investigating material nonpublic information flowing through expert networks. Of particular note here is the use of political intelligence, which requires exceptional diligence and care to ensure that any information one possesses relevant to a trade was properly obtained. (SRZ Alert, Enforcement Update: Insider Trading and COVID-19 Political Intelligence.) In fact, in the prosecution that led to the Second Circuit’s recent decision in United States v. Blaszczak, it was governmental information regarding proposed healthcare rules and reimbursement rates that was held to constitute material nonpublic information.[8]

    Fourth, as in Blaszczak, the government will likely use 18 U.S.C. § 1348, a criminal statute created by the Sarbanes-Oxley Act of 2002, as a further tool in pursuing downstream tippees and others who trade on material nonpublic information. This statute criminalizes a wide range of fraudulent practices connected with securities and commodities. Importantly, unlike Section 10(b), the Second Circuit held in Blaszczak that Section 1348 does not require any showing that the tipper received a “personal benefit” from passing along the information for criminal liability to attach.[9] Thus, while this statute only applies to trading in registered securities, which is a narrower focus than Section 10(b), prosecution under Section 1348 may relieve the government of proving one of the typical elements of insider trading. (SRZ Alert, Insider Trading Law in Flux — What Advisers Need to Know.)

    Disclosure

    With conditions changing so rapidly, the government will likely scrutinize the accuracy of oral and written statements at the time they were made. The SEC has identified disclosure as a major area of focus for 2020.[10] SEC Chairman Jay Clayton recently advised companies to “provide investors with insight regarding their assessment of, and plans for addressing, material risks to their business and operations resulting from the coronavirus.”[11] Information about how the pandemic is affecting a company’s operations, cash flow, asset values and customer behavior is likely of key interest to the investing public. The government will pay careful attention to the ultimate accuracy of the financial information itself as well as any statements about how the company plans to respond to the pandemic and its goals going forward.

    Compliance with GAAP has always been an area of focus for the SEC. But these investigations are not just limited to whether the financial statements comport with GAAP, but whether what the company says about its compliance with GAAP is accurate. In the current crisis, issuers need to analyze the extent of the impacts of coronavirus on their supply chain, communication and other internal controls to determine how the crisis affects their ability to apply GAAP.

    Although, as a general rule, companies are supposed to avoid burying the public in an avalanche of trivial detail,[12] a duty to disclose may arise when previous statements are no longer accurate or may have been rendered misleading in light of later developments, necessitating the issuance of an updated, correct statement.[13] Maintaining this balance will be especially important, and subject to government review, during this time.

    Another likely pitfall in this fast-changing environment is selective disclosure, where updates reach some parties sooner than the market at large. Regulation Fair Disclosure (“Reg FD”) generally requires public companies to disclose material nonpublic information to the public at the same time as or before disclosing the information selectively, such as to analysts, institutional shareholders or other securities industry professionals. Principals, officers and directors fielding requests for up-to-date information must therefore be especially careful to speak accurately and keep the public properly informed.[14]

    Market Manipulation

    The government has a strong interest in maintaining the integrity of the markets and policing any conduct that alters prices or that creates some false appearance of supply, volume or demand to someone’s unfair advantage. For example, the government frequently uses this theory to prosecute “pump and dump” schemes in which sellers go to extensive efforts to advertise a particular stock while acquiring it cheaply, only to rapidly sell off their stores when the price swings upwards.

    The SEC has already suspended trading for two issuers and continues to monitor the market closely.[15] The government may investigate trading practices it believes unfairly take advantage of volatility, which could sweep in a wide swath of market participants who were simply reacting to the volatility and trying to do what they could to generate some liquidity or profit for themselves.

    Schemes

    In times of stress, existing Ponzi schemes and pyramid schemes often unravel as they can no longer support their regular payment obligations. Infamously, Bernard Madoff’s Ponzi scheme collapsed during the financial crisis. Already this Spring, the SEC and DOJ put an end to a Ponzi scheme allegedly perpetrated by a Pennsylvania lawyer.[16]

    By the same token, however, many fraudulent schemes are only getting started during the crisis, taking advantage of people and companies who are increasingly desperate for promises of cash or investments that appear stronger than the volatile stock market.

    As more businesses struggle for liquidity to continue or salvage their operations, they may fail to provide accurate financial information when they apply for financing or other liquidity, and fall subject to government enforcement for bank fraud. The same challenge of keeping financial information accurate can also lead to accounting fraud or tax fraud issues when the mismatch between the financial statements and reality is revealed.

    Scams

    Scams emerging during the coronavirus crisis — and the government’s desire to shut them down and punish those responsible — are not limited to the financial markets.[17]

    Price gouging emerged as a major phenomenon as the coronavirus appeared in the United States, as prices for high-demand items reached multiples of their normal rates on online shopping platforms. Although many platforms have taken action to cut down on these listings, the issue is likely far from resolved. In response, the President recently signed an Executive Order and the Attorney General announced an initiative to tackle price gouging and hoarding of medical supplies.[18] Nonetheless, as the shelves of local stores increasingly lay bare and health authorities advise minimizing contact with others, online shopping platforms may face antitrust enforcement inquiries if they misuse their market power or conspire with the gouging sellers.

    The Antitrust Division, which had already been very active in the financial services arena,[19] is getting ready to handle this expected influx of cases. In late February, it requested funding to hire 55 additional attorneys for fiscal year 2021.[20] The Attorney General has asked the public to be on the lookout for coronavirus fraud and set priorities for antitrust enforcement.[21]

    On online platforms and elsewhere, counterfeit goods are increasingly entering the marketplace, seeking to profit by meeting the extreme demand for particular items even when the product itself does not meet the stated specifications. This is particularly concerning when it comes to protective measures the public is relying on to stem the pandemic, like masks for health professionals and hand sanitizer. Alarmingly, purported coronavirus cures are on sale, none of which have received approval; some of these may well be unsafe to take, and all are unsafe to the extent they do nothing to limit the spread of the virus. The U.S. Attorney’s Office for the Western District of Texas acted quickly, obtaining an injunction to shut down a website promising a vaccine in exchange for credit card information to cover purported shipping charges.[22]

    There has already been a marked increase in cybercrime, involving fake maps of the spread of the virus, malicious links purporting to provide important public safety announcements and phishing attempts hoping to take advantage of workforces continuing their daily tasks from home. (SRZ Alerts, Homeland Security Warns of Coronavirus-Related Cybersecurity Risks — Considerations for Private Fund Managers; Broker-Dealers: B-D Guidance on Increased Cybersecurity Risks Due to the COVID-19 Pandemic.) There will be significant prosecution activity under the Computer Fraud and Abuse Act and other statutes for this conduct. (E.g., New York Law Journal article, Different Strokes: Interpreting Computer Fraud and Abuse Act.)

    Several scams target older individuals and those who care for them, taking advantage of their fear of the coronavirus’ more severe impact on the elderly and the fact that older persons are isolating themselves, even from their families, in the hopes of preserving their health. These scams have countless incarnations and will be vigorously prosecuted under elder law statutes as well as the highly flexible wire fraud and mail fraud criminal statutes.

    In the midst of the high demand for health care and the possible overwhelming of our health care system in many parts of the country, regulators will be vigilant about investigating state and federal program fraud, including Medicare and Medicaid, false insurance claims and other false claims as people take advantage of the chaos. If the government itself takes on an increased role as a provider of health services or supplies, there will likely be an increase in significant False Claim Act lawsuits, with a corresponding uptick in intervention by the DOJ.

    Moreover, if the President activates any authority under the Defense Production Act, that will create entirely new avenues for enforcement, as that statute criminalizes willful violations of the Act.[23] The government may seek to apply these provisions broadly to ensure that no one defrauds the government or the public in ways that hamper the purpose of the President’s orders.

    Finally, as employees — including officers, directors and other senior officials — begin to believe their enterprises are failing, some may transfer assets to themselves in the hopes of getting paid before the business goes bust. These transfers may be criminally prosecuted under statutes prohibiting embezzlement, bankruptcy fraud, wire fraud and mail fraud. This same conduct may also result in civil liability, regulatory enforcement, and additional penalties in a bankruptcy or liquidation context (e.g., fraudulent conveyances, transfers and preferences).

    Given all of this activity, caution is clearly warranted for everyone to remain vigilant for potential scams. To the extent the government manages to recover ill-gotten gains, however, the government often seeks to return those funds to victims as well as whistleblowers who assist the government in detecting and rooting out illegal behavior.

    In the wake of the current crisis, a heavy wave of enforcement is likely on the way. Many will be subject to investigation for their conduct during the coronavirus crisis, both intentional and accidental wrongdoers. In this regard, history tells us that the SEC, DOJ and other agencies will seek to make examples out of those they perceive crossed a line, especially during a public health emergency and unprecedented global pandemic.

    Authored by Adam S. Hoffinger, Douglas I. Koff, Gary Stein, Peter H. White, Craig S. Warkol, Noah N. Gillespie and Amanda C. Wichot.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] SEC, Enforcement Actions Addressing Misconduct that Led to or Arose From the Financial Crisis (Oct. 7, 2016), available here.

    [2] Att’y Gen. William Barr, Memo to all U.S. Attorneys, COVID-19 – Department of Justice Priorities (March 16, 2020), available here.

    [3] The SEC pursued 528 actions against 1,093 individuals and entities for insider trading during the period 2008-2018. During that same period, the U.S. Attorney for the Southern District of New York alone secured the conviction, by trial or guilty plea, of 105 defendants in insider trading cases. Taleah E. Jennings, Penalties, Short-Swing Profits, and Whistleblower Awards at 21-3, in Answer Book, infra.

    [4] Stephanie Avakian & Steven Peikin, SEC, Statement Regarding Market Integrity (Mach 23, 2020), available here. For more detail on this nuanced area of the law, see Harry S. Davis, ed., Insider Trading Law and Compliance Answer Book (Practising Law Institute 2020) (“Answer Book”).

    [5] Compare United States v. Rajaratnam, No. 11-4416-CR, 2013 U.S. App. LEXIS 12885, at *4-6 (2d Cir. June 24, 2013) (following Rule 10b5-1 to hold that “knowing possession” is sufficient but noting that the jury instructions at issue contained a component that required the “use” of the material nonpublic information), with United States v. Jun Ying, No. 1:18-cr-74-AT, 2018 WL 6322308, at *5 (noting the Eleventh Circuit does not follow Rule 10b5-1 in civil or criminal actions but instead requires “use” of the material nonpublic information).

    [6] For more information, see Gary Stein and Martin L. Perschetz, Chapter 5, Scienter and Trading “On the Basis Of,” in Answer Book.

    [7] For more information, see Howard Schiffman, Chapter 10, Tipper and Tippee Liability, in Answer Book.

    [8] United States v. Blaszczak, 947 F.3d 19, 26-29 (2d Cir. 2019).

    [9] Id. at 35.

    [10] Chairman Jay Clayton, SEC, Proposed Amendments to Modernize and Enhance Financial Disclosures; Other Ongoing Disclosure Modernization Initiatives; Impact of the Coronavirus; Environmental and Climate-Related Disclosure (Jan. 30, 2020), available here; see also SEC Office of Compliance Inspections and Examinations, 2020 Examination Priorities, available here.

    [11] Press Release, SEC, SEC Provides Conditional Regulatory Relief and Assistance for Companies Affected by the Coronavirus Disease 2019 (COVID-19) (March 4, 2020), available here; see also SEC Division of Corporate Finance, Coronavirus (COVID-19) Disclosure Guidance (March 25, 2020) (highlighting several areas to consider in formulating appropriate disclosure during the pandemic).

    [12] Basic Inc. v. Levinson, 485 U.S. 224, 231 (1988) (quoting TSC Indus., Inc. v. Northway, Inc., 426 U.S. 438, 448-49 (1976)).

    [13] See Matrixx Initiatives, Inc. v. Siracusano, 563 U.S. 27, 38 (2011) (an omission becomes “material” if a reasonable investor would find the omitted fact would have altered the “total mix” of information available); Gallagher v. Abbott Labs., 269 F.3d 806, 807-10 (7th Cir. 2001) (finding no duty to correct and requiring positive law to impose the duty to disclose).

    [14] For more information, see Douglas I. Koff, Chapter 11, Regulation Fair Disclosure, in Answer Book.

    [15] SEC, Coronavirus (COVID-19) Response (last updated March 24, 2020), available here.

    [16] Press Release, DOJ, Pennsylvania Attorney Indicted for Role in $2.7 Million Ponzi Scheme (March 24, 2020), available here.

    [17] DOJ’s initial analysis of the pandemic goes so far as to consider charging persons who intentionally spread the virus with terrorism. Deputy Att’y Gen. Jeffrey Rosen, Memo, Department of Justice Enforcement Actions Related to COVID-19 (March 24, 2020), available here.

    [18] Makini Brice & Sarah N. Lynch, U.S. launches probes as Trump bans hoarding, price gouging to combat coronavirus, Reuters (March 23, 2020), available here.

    [19] E.g., Deputy Ass’t Att’y Gen. Richard A. Powers, Remarks on the State of Criminal Antitrust Enforcement in 2020 (Miami, Fl. Feb. 7, 2020), available here (highlighting several recent prosecutions directed at “combatting collusion in global financial markets”).

    [20] DOJ Antitrust Division, FY 2021 Budget Request at a Glance, available here.

    [21] Press Release, DOJ, Attorney General William P. Barr Urges American Public to Report COVID-19 Fraud (March 20, 2020), available here; DOJ Antitrust Division & FTC Bureau of Competition, Joint Antitrust Statement Regarding COVID-19 (March 2020), available here.

    [22] Press Release, DOJ, Justice Department Files Its First Enforcement Action Against COVID-19 Fraud (March 22, 2020), available here.

    [23] 50 U.S.C. § 4513 (the willful performance of a prohibited act or failure to perform a required act is punishable by a fine of $10,000, a year in prison, or both).


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Douglas I. Koff

    Partner

    New York – 919 Third Avenue

    More insights

  • SEC Reporting Companies Granted Further Extension of Filing Relief Due to COVID-19

    SEC Reporting Companies Granted Further Extension of Filing Relief Due to COVID-19

    ARTICLE / CLIENT ALERT / US POLICY

    SEC Reporting Companies Granted Further Extension of Filing Relief Due to COVID-19

    March 27, 2020

    Read time: 4 min

    Key takeaways
    Overview

    On March 25, 2020, the U.S. Securities and Exchange Commission issued a new exemptive order[1] extending the temporary relief for reporting requirements under certain provisions of the Securities Exchange Act of 1934, as amended (“Exchange Act”) and the rules thereunder for public companies and other filers, subject to certain conditions. The new order supersedes a similar exemptive order issued by the SEC on March 4, 2020.[2]

    The March 4, 2020 order provided that certain filings[3] whose original deadline fell between March 1 and April 30, 2020 were allowed to be filed up to 45 days after they would otherwise be due if the filer is unable to meet the deadline due to COVID-19. The new order extends the April 30, 2020 date through July 1, 2020.

    The exemption is available to registrants subject to the reporting requirements of Exchange Act Section 13(a) or 15(d). The exemption is also available to any person required to make any filings with respect to such a registrant, including pursuant to Section 13G. However, it should be noted that the orders do not offer relief for Schedule 13D filings, amendments to Schedule 13D filings or Section 16 filings (Form 3 and Form 4).[4]

    The SEC confirmed in its press release announcing the order that, so long as a registrant properly complies with the conditions for using the extension, the SEC will consider such registrant current and timely in its Exchange Act filing requirements for purposes of Form S-3, Form F-3 and Form S-8 eligibility and the current public information eligibility requirements of Rule 144(c). Although not specifically addressed in the SEC’s press release, we would expect that former shell companies will also be deemed to remain current under Rule 144(i).

    In order to take advantage of such exemption, a registrant must furnish to the SEC a Form 8-K or, if for foreign private issuers, a Form 6-K no later than the original filing deadline of the report.[5] The Form 8-K must:

    1. State that the registrant is relying on the order;
    2. Provide a brief description as to why they could not meet the original deadline;
    3. Provide an estimated date on which the report or filing is to be filed;
    4. If applicable, provide a company specific risk factor or factors explaining the impact, if material, of COVID-19 on its business; and
    5. If the filing delay is due to any person other than the registrant, such as an auditor, provide as an exhibit a statement signed by such person stating the specific reasons for the delay.

    Registrants relying on these orders have generally used Item 8.01 – Other Events to announce the delay.

    Registrants considering relying on these orders should also consider whether there are any other deadlines for filing reports that may apply. In particular, registrants should consider whether there are any reporting covenants in any debt agreements that may impose a separate deadline.

    Authored by Stuart D. Freedman, Antonio L. Diaz-Albertini, and Evan A. Berger.

    If you have any questions concerning this Alert, please contact your attorney or one of the authors.

    In depth
    Authors
    More insights

  • Curve-Flattening Travel Immobility Leads to Cross-Border Tax Challenges for Companies and Employees

    Curve-Flattening Travel Immobility Leads to Cross-Border Tax Challenges for Companies and Employees

    ARTICLE / CLIENT ALERT

    Curve-Flattening Travel Immobility Leads to Cross-Border Tax Challenges for Companies and Employees

    March 26, 2020

    Read time: 11 min

    Key takeaways
    Overview

    Covid-19 is creating unexpected tax exposure for foreign-based businesses with employees detained in the US and vice versa as companies may now find themselves with more sourced income than expected causing unforeseen tax liability and filing requirements. Until the US and other countries provide temporary relief, businesses need to stay vigilant to avoid unforeseen tax traps in their supply chain infrastructure.

    Update: Click here to view our comment letter to the IRS requesting clarification and expansion of the recent IRS guidance.

    In depth

    Border closures, travel bans and stay-at-home orders have become commonplace throughout the world during the COVID-19 pandemic. This global immobility has been instituted for a good cause – to flatten the curve of the spread of COVID-19. On March 19, 2020, the US Department of State elevated its Travel Advisory to its highest possible level – Level 4. This means that the Department of State advises all US citizens to avoid international travel. Similar advice is recommended by countries around the world.

    For US citizens abroad, the Department of State says, “US citizens who live in the United States should arrange for immediate return to the United States, unless they are prepared to remain abroad for an indefinite period.” In many cases, US citizens are returning to the US temporarily from a country in which they may be employed by a local employer. In other cases, residents of a foreign jurisdiction may be forced to remain in the US indefinitely because they have fallen ill, the conditions in their home countries are unsafe or otherwise.

    This immobility presents cross-border tax challenges to individuals and companies who suddenly find themselves conducting operations in a foreign jurisdiction. Specifically, individuals who are nonresidents of the US may find themselves becoming US tax residents subject to tax on worldwide income. Similarly, non-US companies may find themselves conducting a trade or business in the US based on the activities of employees who are present in the US during the pandemic. Conversely, US companies may find that they have established a permanent establishment in a foreign jurisdiction because employees may be conducting business operations in a non-US jurisdiction. This articles explores some of the tax implications of these scenarios.

    Residency Considerations for Employees
    Mobility restrictions resulting from the COVID-19 pandemic may give rise to situations where employees of multinational companies become tax residents outside of their home country.

    In the US, there are generally three ways by which an individual is considered a US income tax resident, namely, being a US citizen, a lawful permanent resident (i.e., a Green Card holder), or “substantially present” in the US. To the extent a nonresident employee becomes a US income tax resident, the employee becomes subject to US income tax on worldwide income.

    In general, a nonresident employee will meet the substantial presence test if the employee is present in the US for at least 183 days during any calendar year, or an average of at least 122 days over a three-year period computed by applying a statutory formula. Exceptions to the substantial presence test are limited. For example, a nonresident employee will not be a US tax resident if the employee (i) spent less than 183 days in the US during a calendar year and (ii) can (a) establish that their “tax home” is in a foreign country and (b) demonstrate they have a closer connection to that foreign country. A nonresident employee that is a tax resident in a jurisdiction with which the US has an income tax treaty, may be able to utilize a treaty “tie-breaker” provision of the relevant tax treaty even where the employee meets the substantial presence test by spending more than 183 days in the US in a single year.

    Another exception to the substantial present test involves medical conditions. That exception applies if a nonresident individual is unable to leave the US because of a medical condition that arose while such individual was present in the US. In other words, days are counted for purposes of the substantial presence test if a nonresident employee enters the US for medical treatment or is otherwise aware of a condition prior to entering the US regardless of whether the individual required medical treatment for such condition. Moreover, the medical condition exception ceases to apply if, on becoming well enough to travel, the individual remains in the US beyond a reasonable amount of time to arrange travel outside of the US. In view of the current public health crisis, the IRS has been requested to expand the medical condition exception to include nonresident individuals who cannot travel due to the COVID-19 pandemic. Thus far, the IRS has not allowed for any exceptions.

    Even if a nonresident employee is not substantially present in the US, and in the absence of an income tax treaty, the performance of personal services in the US (as described below) may still cause the employee to incur a US income tax liability to the extent the compensation sourced to the US exceeds a certain de minimis exception as described below.

    Conversely, foreign country tax residency rules should be considered for US tax resident employees trapped in foreign countries because of COVID-19. Generally, US income tax residents have an election to exclude their foreign earned income (up to $107,600 in 2020) from their US taxable income. However, to make such an election, the individual’s “tax home” must be in that foreign country, which is unlikely to be the case in the event of temporary residency. As a result, a US tax resident employee unable to travel because of COVID-19 must assess whether she will or have become an income tax resident of a foreign country, whether she will be able to claim an income tax treaty “tie-breaker” position, or whether she may claim foreign tax credits in the US to the extent she is required to pay foreign income taxes.

    Sourcing of Income from Performance of Personal Services
    An employee who is detained within the US and works remotely can cause income sourcing issues to their employer. Even if an employee is not present in the US long enough to become a tax resident, an employee who performs personal services on behalf of her employer while in the US can cause the income earned by the employer on account of the employee’s services to be US source income. The consequences of this are manifold.

    All compensation for labor or the performance of personal services performed in the US is treated as US source income. This means that the income earned by the employer as a result of the labor of employees who are temporarily detained within the US, will be US sourced. In particular, a foreign-based multinational may now find itself with more US sourced income than it expected. Indeed, a company who might otherwise have no employees in the US, may find itself with unforeseen US tax liability and filing requirements.

    Domestic entities may also suffer unanticipated tax consequences, particularly those with foreign operations and who have made the operating decision based on the availability of the foreign tax credit. In general, a domestic company is entitled to credit against its US tax liability the foreign income taxes paid. Under the foreign tax credit rules, the amount of this credit is limited to a fraction of the US income tax liability. Ignoring some of the finer details, the numerator of that fraction is essentially the company’s foreign source income and the denominator is the company’s worldwide income. If an employee of a foreign branch who would ordinarily work in a foreign jurisdiction works while in the US, the result is that the numerator of this fraction is reduced and therefore the company will be entitled to less foreign tax credit, notwithstanding that the tax liability in the foreign jurisdiction may remain the same.

    To mitigate these consequences, the employer should evaluate and determine whether the facts may support a position that the portion of its income earned due to this employee’s labor performed while in the US is relatively small. In that case, less of the company’s income will be treated as US source income. Generally, this may be done by showing that the income earned is predominantly attributable to some other item or activity, for example, employees working outside of the US, plant and equipment or intellectual property located outside of the United States.

    Companies Should Reconsider their Nexus to the Source Jurisdiction
    COVID-19 may have a significant impact on nonresident companies that have employees temporarily present in the US. Under US domestic law, aside from a modest $3,000 de minimis exception, a nonresident company is taxable in the US on a net basis to the extent it earns income that is effectively connected to a US trade or business (the ECI Regime). A nonresident company is generally engaged in a US trade or business if its employees or personnel perform personal services within the US at any time during the taxable year. Certain exceptions apply for nonresidents that trade in securities or commodities. However, in other cases, it may only take the act of one employee performing services in the US to cause the nonresident company to be engaged in a US trade or business. Nonresidents that are currently faced with the issue of having employees temporarily present and working in the US because of COVID-19, should consider its US tax filing obligations and whether any of its income is taxable under the ECI Regime. It should also examine its employees’ activities to determine whether they are in fact “performing” services. In borderline cases, the nonresident company should consider filing a protective Form 1120-F to claim no tax residence in the US and begin the running of the three year statute of limitations clock.

    In cases where the nonresident company qualifies for the benefits of a US income tax treaty, it should consider whether the permanent establishment (PE) article provides relief from its US tax nexus. Nonresidents should be wary of the fixed place of business PE (FPOB PE) provision if they have an employee currently working out of an office in the US. Interesting questions arise in the case of employees working in other fixed locations, such as a temporary or permanent residence. Even if no FPOB PE exists, most, if not all, US income tax treaties contain PE provisions on dependent agents habitually negotiating and concluding contracts in the US, subject to the potential application of specific activity exceptions for functions thought to be “preparatory or auxiliary.” Nonresident companies should consider the extent of their agents’ activities, for example, whether they rise to the level of “habitual,” and to the extent possible, might want to consider restricting their agents’ contracting and negotiating power to avoid creating a PE. Further, some US income tax treaties contain personal services PE provisions that focus on the number of days a nonresident company’s employees or personnel spend in the US. Due to limitations on travel to or from the home jurisdiction, it is possible that an employee may spend more time than expected in the US. Of course, even if a nonresident company has a PE in the US, it should carefully examine the amount of its business profits are “attributable to” such PE based upon the facts and circumstances of the given arrangement. Nonresident companies should assess their reporting positions to determine whether they have US tax filing obligations and potential US tax exposure.

    In light of COVID-19, US companies face similar challenges to the extent they have employees temporarily stranded in a local jurisdiction. US companies should consider whether they have nexus to the particular jurisdiction, and if they are required to pay tax in the local jurisdiction and comply with local tax filing obligations. In addition, the application of the US Subpart F rules in many cases hinges on the location of various activities of foreign subsidiary employees (for example under the foreign base company sales and services rules), and thus may require reevaluation if certain functions are moved from one foreign country to another. Further, US companies should monitor whether any of their foreign subsidiaries’ employees are performing services in the US. It is possible that a foreign subsidiary might also be subject to the ECI regime, which can lead to tax inefficiencies in their supply chain.

    It is hoped that the US and other countries around the world will provide temporary relief from tax exposures of this nature stemming from disruptions caused by the pandemic. In the meantime, virtually all multinational enterprises need to be vigilant for new traps that may have arisen within their supply chain structures.

    Authors

    Michael J. Bruno

    Partner

    Miami

    Gregory Weigand

    Counsel

    Miami, New York – One Vanderbilt Avenue

    David G. Noren

    Partner

    Washington, DC

    More insights

  • Secretary Azar Calls on Governors to Modify Regulations to Expand Healthcare Workforce

    Secretary Azar Calls on Governors to Modify Regulations to Expand Healthcare Workforce

    ARTICLE / CLIENT ALERT

    Secretary Azar Calls on Governors to Modify Regulations to Expand Healthcare Workforce

    March 26, 2020

    Read time: 9 min

    Key takeaways
    Overview

    In a March 24, 2020, letter, Secretary of Health and Human Services Alex Azar asked state governors to take immediate action to modify state law and regulations to extend the capacity of the healthcare workforce to address the Coronavirus (COVID-19) pandemic. Notwithstanding this call for a “whole-America response” to the crisis, states are pursuing their own approaches to modifying their healthcare laws and regulations.

    In depth

    In a letter dated March 24, 2020 (the Letter), Secretary of Health and Human Services Alex Azar has asked the governors of the United States to “take immediate action” to modify state law and regulation and take other actions “to extend the capacity of the health care workforce to address the [Coronavirus (COVID-19)] pandemic.” Noting that healthcare providers are at risk of infection and “some may be unable to treat patients due to quarantine,” the secretary asks the governors for help to “ensure health professionals maximize their scopes of practice and are able to travel across state lines or provide telemedicine to communities where they are needed most.”

    Secretary Azar makes eight recommendations to modify regulatory and legal requirements around licensure, standard of care, scope of practice, supervision requirements, licensure and certification requirements, student practice and malpractice insurance in an attempt to free up resources. These recommendations are also specified and further explained in an attached document, “Guidance to States: Lifting Restrictions to Extend the Capacity of the Health Care Workforce during the COVID-19 National Emergency” (the Guidance).

    Among other things, the Letter may put to rest any speculation on the implications of Vice President Pence’s statement at a Wednesday, March 18, 2020, White House press briefing that:

    “[W]ith regard to medical personnel, at the President’s direction, the [Department of Health and Human Services] is issuing a regulation today that will allow all doctors and medical professionals to practice across state lines to meet the needs of hospitals that may arise in adjoining areas.”

    While the Vice President’s comments raised the perhaps-enticing possibility of a temporary federalization of physician licensure, Secretary Azar’s Letter points in another direction. In fact, the Guidance indicates that, at least at present, the secretary does not have the authority to override state law. In the Guidance, the secretary notes that while he may waive requirements related to Medicare, Medicaid and CHIP Program reimbursement, “health care providers must still comply with various state laws and requirements.” Alternatively, the secretary may simply have determined that taking such a dramatic step would have been counterproductive in the effort to marshal resources to address the pandemic.

    Regardless of reason, the secretary calls on the states to take action relative to the eight recommendations:

    1. Modify Provider Licensure Requirements to Facilitate Cross-Border Practice

    The secretary’s Guidance recommends that states temporarily waive restrictions on providers licensed in other states and consider ways to process rapidly the waivers. The secretary notes that some states may already have flexibility to allow licensure exceptions during periods of emergency and others may have laws triggered by emergency declarations to allow for temporary licenses, and he urges these states to activate such laws. The secretary’s Guidance also urges states to encourage licensing boards to establish enforcement moratoria related to licensure violations.

    The Letter’s description of this action item notes specifically that the loosening of licensure requirements should allow professionals to practice “through telemedicine.” The secretary also identifies retired healthcare professionals as potential additions to the healthcare workforce. In addition, the Letter, a more informal document than the Guidance, reflects an urgency not reflected in the Guidance:

    “I ask your assistance to immediately activate these and other health care professional licensure exceptions to the fullest extent appropriate, and to waive any state licensure or certification fees, in order to extend the capacity of health care professionals to fully assist in responding to the COVID-19 emergency.”
    This urgency may also be reflected in the secretary’s suggestion that if the governors do not have the present authority to take these steps then they should “consider working with their legislatures to enact such mechanisms.”

    Most states have already taken action to relieve licensure requirements for healthcare workers. Each state’s regime is different, however, and not all states have taken action; the waivers range from being broad and self-implementing (as in Connecticut) to limited waivers that only apply in specific instances (as in the District of Columbia, where licensure is only waived for professionals providing services for a healthcare facility or an existing patient located in the district). Ultimately, the country remains a patchwork of conflicting and distinct regulations, even though many have been liberalized to allow for easier cross-border practice.

    2. Waive Restrictive Telemedicine Regulations

    The Guidance recommends waivers of statutes and regulations that mandate specific telehealth modalities and practices necessary to establish the patient-provider relationship and to support diagnosis and treatment recommendations. The secretary does not describe or discuss this recommendation in much detail in either the Letter or the Guidance, but it does include some “hedge” language that does not appear in any of the other recommendations related to patient care.

    Specifically, in the Guidance, the recommendation to loosen telemedicine regulations is qualified “[t]o the extent permissible.” Similarly, the Letter recommends waiving statutory and regulatory standards that are “not necessary for the applicable standards of care” to establish a patient-provider relationship. The secretary does not specifically describe or discuss these qualifications in either the Letter or the Guidance, leaving individual states with enormous discretion to determine their meaning for themselves.

    Many states have already taken steps to modify their telemedicine laws to provide for greater utilization. Indeed, the licensure actions taken by many states have alleviated, at least temporarily, a significant burden for multi-state telemedicine programs. States have been far less likely to modify requirements around telemedicine in the context of the standard of care, however, which are much more nuanced than the licensure requirements. Nonetheless, states have acted. In Maine, for example, the Department of Health and Human Services changed rules to allow for prescribing via telehealth, and in New Hampshire providers have been temporarily allowed to provide telehealth services through all modes, including audio-only modalities.

    3/4. Waiver of Other Scope of Practice Requirements/Waive Geographic Restrictions Relative to Supervision

    The third and fourth recommendations are presented as alternatives and represent perhaps the boldest and most sweeping recommendations. In his Letter, the secretary asks that governors “[r]elax scope of practice requirements for healthcare professionals, including allowing professionals to practice in all settings of care.” The potential breadth is clearly intended as both the Letter and Guidance describe a wide array of waivers and modifications involving:

    • Written supervision or collaboration agreements.
    • Limitations on the number of non-physician healthcare professionals a physician may supervise.
    • Restrictions on the types of nurse practitioners (NPs), other registered nurses, physicians and other caregivers that can furnish care in the home or other settings.
    • Expanding allowable activities of non-physician health professionals, including emergency medical technicians and paramedics.

    In addition, the Guidance recommends that the states encourage the applicable licensing boards to adopt enforcement moratoria with respect to these substantive areas.

    Alternatively, the Guidance and Letter suggest lifting geographic limitations on physician supervision of NPs and physician assistants (Pas). The Guidance and Letter specifically contemplate physician supervision of these professionals via telemedicine services or other electronic means.

    These recommendations, if adopted, could upend carefully constructed operating models based on professional evaluations of qualification, and are so sweeping that we would not be surprised if states took a more cautious approach.

    Nonetheless, some states are already taking some of these actions in order to expand access to healthcare resources. For example, by executive order in Michigan, non-nursing assistants are empowered to help feed or transport a patient consistent with a care plan.

    5. Rapid Licensure/Certification and Relicensure/Recertification

    The secretary recommends easing the administrative burden for licensure and certification and reducing its cost through fee waivers. Some states have already taken these actions.

    6. Alleviate Malpractice Liability

    Recognizing that healthcare professionals may have liability concerns and face real liability risk, the secretary’s recommendations include making public all of the different liability protection mechanisms that may exist within a state. In addition, the secretary suggests that governors work with their state insurance commissioners to nullify malpractice policy provisions that would prevent insurance coverage for healthcare professionals responding to COVID-19.

    7. Utilize Medical Students

    The secretary recommends that legal and regulatory constraints to allowing medical students to treat patients under the supervision of a licensed physician be lifted.

    8. Signature-Less Pharmaceutical Deliveries

    Finally, the secretary recommends allowing signature-less deliveries of pharmaceuticals to assist in adhering to social distancing standards. This is another area that states have been actively monitoring and on which they have provided guidance (the Ohio Board of Pharmacy, for example, has highlighted that existing law does not require a signature for picking up prescriptions).

    The secretary’s recommendations are intended to broadly apply to and address all healthcare services delivered within the scope of the practitioner’s license, and not just for COVID-19 related cases. This is a different approach than that taken by many states, which have pursued a more conservative approach to various modifications. California and Texas, for example, both waived licensure requirements, but both require an in-state sponsor to qualify. In the case of California, the sponsor must be a medical facility or staffing agency (and the care must be provided for that entity), while in Texas, individual physicians can sponsor an out-of-state practitioner.

    Notwithstanding the secretary’s goal to “carry out a whole-America response,” his call to action is unlikely to untangle the legal and regulatory webs underlying our healthcare industry. It may, however, spur state action to permit more robust utilization of healthcare resources, even if within a complicated regulatory regime.

    Authors
    More insights

  • HHS OIG Establishes Portal and Process to Provide Guidance on Anti-Kickback and Beneficiary Inducement Statutes During COVID-19 Crisis

    ARTICLE / CLIENT ALERT

    HHS OIG Establishes Portal and Process to Provide Guidance on Anti-Kickback and Beneficiary Inducement Statutes During COVID-19 Crisis

    March 26, 2020

    Read time: 4 min

    Key takeaways
    Overview

    The US Department of Health and Human Services, Office of Inspector General has created an information portal and established a process to provide guidance on the application of the Anti-Kickback Statute and Beneficiary Inducement Statute to COVID-19-connected arrangements. This process permits the public to submit questions via email to the OIG, and the portal will include responses to frequently asked questions.

    In depth

    In recognition of the current public health emergency posed by Coronavirus (COVID-19), the US Department of Health and Human Services, Office of Inspector General (OIG) announced on March 25, 2020, that it would entertain questions regarding the application of OIG’s authorities—including the federal anti-kickback statute (AKS) and the beneficiary inducements civil monetary penalties law (Beneficiary Inducement Statute)—to arrangements connected to COVID-19. In a departure from its typical and more time-consuming practice of encouraging the use of its existing advisory opinion process to answer such questions, OIG established an email address, OIGComplianceSuggestions@oig.hhs.gov, for the public to submit questions. Submissions should include enough details to permit OIG to understand the facts of the arrangement, including the parties and material terms.

    OIG will review all submissions and use them to develop frequently asked question (FAQ) responses, which OIG will publish on its website for COVID-19-related information, oig.hhs.gov/coronavirus/. OIG cautions, however, that it is not obligated to respond to, publish or issue public responses on all questions, or to take any other action. It is not clear whether OIG will respond directly to the individual or entity submitting the question in addition to using the questions to create FAQs.

    Putting that question aside, the public should benefit from OIG taking this step to increase its public-facing guidance on these critical issues, likely on a faster timeframe than advisory opinions or other industry guidance. Unlike OIG’s sister agency, the Centers for Medicare and Medicaid Services (CMS)—which has historically used FAQs to provide public guidance on the application of the physician self-referral law (or Stark Law)—OIG has been reluctant to use FAQs to provide similar guidance on the AKS and Beneficiary Inducement Statute. The approach here is notable both for its departure from OIG’s typical approach as well as a potential departure from where CMS is heading in its response to the COVID-19 crisis.

    During an American Health Law Association webinar, Chief Counsel Gregory Demske stated that OIG does not intend to issue broader waivers under the AKS Beneficiary Inducement Statute. While CMS initially took a similar approach by including the Stark Law in its case-by-case Section 1135 waivers, CMS is now considering issuing a blanket Stark Law 1135 waiver. It is important to remember, however, that some arrangements may implicate both the AKS and Stark Law and that the government’s waiver of one of these laws does not automatically waive the other. Risks may arise if an arrangement falls under the scope of both laws, but only one has been waived.

    OIG’s first FAQs, related to the OIG Policy Statement Regarding Physicians and Other Practitioners That Reduce or Waive Amounts Owed by Federal Health Care Program Beneficiaries for Telehealth Services During the 2019 Novel Coronavirus (COVID-19) Outbreak issued on March 17, 2020, are available on the OIG COVID-19 portal and discussed in our related On the Subject.

    Authors

    James A. Cannatti III

    Partner

    Washington, DC

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Monica Wallace

    Partner

    Chicago

    More insights

  • Second Circuit Asks Whether It Should Further Limit FCPA’s Application

    Second Circuit Asks Whether It Should Further Limit FCPA’s Application

    ARTICLE / CLIENT ALERT

    Second Circuit Asks Whether It Should Further Limit FCPA’s Application

    March 26, 2020

    Read time: 5 min

    Key takeaways
    Overview

    On March 11, 2020, the Second Circuit heard arguments in United States v. Chi Ping Patrick Ho, a case testing the reach of the Foreign Corrupt Practices Act (FCPA) much like the 2018 case United States v. Hoskins. And, once again, the Court raised serious questions about the DOJ’s attempt to apply that Act broadly.

    In depth

    In 2018, the US Court of Appeals for the Second Circuit rejected a broad reading of the Foreign Corrupt Practices Act (FCPA) by the US Department of Justice (DOJ), and issued a ruling that limited the reach of the Act in United States v. Hoskins, 902 F.3d 69 (2d Cir. 2018). On March 11, 2020, the Second Circuit heard arguments in United States v. Chi Ping Patrick Ho, another case testing the reach of the FCPA. And, once again, the Court raised serious questions about the DOJ’s attempt to apply that Act broadly.

    In December 2018, Chi Ping Patrick Ho, a Hong Kong official who ran a research organization run by CEFC China, was convicted of one count of conspiring to violate the FCPA, four counts of violating the FCPA, and additional counts for money laundering. DOJ alleged that Ho, on behalf of the Chinese conglomerate CEFC, had offered a $2 million cash bribe, hidden within gift boxes, to the president of Chad in an effort to obtain oil rights from the Chadian government. The president rejected the offer, and CEFC China did not obtain the advantage allegedly sought through the bribe offer. Ho then allegedly caused a $500,000 bribe payment to be made—via wire through the United States—to Uganda’s foreign affairs minister, and schemed to make a similar payment to Uganda’s president, in exchange for partnering in joint ventures in that country.

    Ho appealed to the Second Circuit, challenging both his FCPA and money laundering convictions. While the money laundering charges does not seem vulnerable to a jurisdictional attack, the Court appeared to view the FCPA as more susceptible to a jurisdictional challenge. With respect to the FCPA violations, Ho argued that the “government’s theory of the case was internally inconsistent and legally insufficient.” In particular, DOJ rested its case on two theories. First, it claimed that the FCPA applied because Ho was an officer of a “domestic concern” under 15 U.S.C. §§ 78dd-2. That provision applies to domestic concerns and to their officers, directors, employees, agents or stockholders. Second, DOJ argued that the FCPA applied because Ho’s conduct fell under Section 78dd-3, a provision that applies to those who are not domestic concerns, but who commit their criminal acts “while in the territory of the United States[.]”

    According to Ho, he can be subject to either one provision or the other, but not both. Ho pointed to the legislative history of § 78dd-3, noting that the provision was enacted 21 years after § 78dd-2, and that Congress intended the two provisions to be mutually exclusive. Ho noted that the Senate’s Committee Report stated the legislation was intended to provide for penalties for persons not covered by § 78dd-2.

    DOJ argued that there was no ambiguity in the statutory language and thus it was inappropriate to consider the legislative history. Nonetheless, DOJ argued that nothing “in the language of the FCPA so much as suggests that Congress intended for the Government to have to choose to charge a given defendant under only one section, when he may have violated more than one section, removing an otherwise-applicable statute, with a different element, from the jury’s consideration.”

    At oral argument, the Second Circuit panel focused on this issue, asking how a defendant could be guilty of both provisions. The panel further pressed DOJ on whether there were “two distinct wrongs” in the conduct at issue. DOJ asserted that helping a domestic organization carry out bribery and traveling to the United States to further an alleged scheme were two distinct acts that Congress intended to criminalize under the FCPA. Ho’s counsel, however, pointed to Hoskins, in which the Second Circuit had already found that § 78dd-3 was meant to cover conduct not already addressed by the existing provisions.

    It is not yet clear how the Second Circuit will decide the Ho case, or when we can expect a decision. Nonetheless, over the past decade, DOJ has applied a broad reading to the FCPA. Hoskins was significant because it was the first case that reigned in the DOJ’s broad reading of the FCPA. The question now is whether Ho will be the second.

    Authors

    Gordon A. Greenberg

    Counsel

    Los Angeles

    Paul M. Thompson

    Partner

    Washington, DC

    More insights

  • The Novel Coronavirus (COVID-19) and its Impact on Ambulant Doctor Offices in Germany

    The Novel Coronavirus (COVID-19) and its Impact on Ambulant Doctor Offices in Germany

    ARTICLE / CLIENT ALERT

    The Novel Coronavirus (COVID-19) and its Impact on Ambulant Doctor Offices in Germany

    March 26, 2020

    Read time: 2 min

    Key takeaways
    Overview

    Physicians and their personnel working in ambulant doctor offices are being affected by the consequences of Coronavirus (COVID-19) in a particular way. The German Parliament, the German self-governing bodies of the ambulant physicians and other public authorities have issued measures and enacted special regulations for the healthcare sector to handle and reduce the health risk of COVID-19, and help healthcare professionals financially during the pandemic period. These new temporary guidelines and code of conducts are to be observed to ensure health and safety to physicians, patients and others.

    This article provides an overview of the applicable regulations and guidelines for the healthcare sector and is intended to provide general guidelines for physicians about how they should organize their practices in the current time.

    Read full article in German here.

    In depth
    Authors
    More insights

  • What COVID-19 Means for Renewable Projects and Financing

    ARTICLE

    What COVID-19 Means for Renewable Projects and Financing

    March 26, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors

    Carl J. Fleming

    Partner

    Washington, DC

    Edward Zaelke

    Partner

    Los Angeles

    Seth B. Doughty

    Partner

    Los Angeles

    More insights